Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-009718

Chief Financial Officer sold 399 shares at $11.32 ($4,517)

From the SEC's structured data for this filing

Trades in this filing

Trigilio Jeffrey · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-03-20 Sale : show line 1 in the form −399 $11.32 $4,517 88,003 D
Open-market sales · 399 sh · avg $11.32 · $4,517
Loading xslF345X04/doc4.xml…